Is early-onset cancer an emerging global epidemic?October 5, 2022Preventive CareBreast CancerHead & Neck/Thyroid CancersGastrointestinal CancerGenitourinary CancerRenal Cell Carcinoma
Adjuvant nivo+ipilimumab fails in kidney cancer, in contrast to pembroOctober 4, 2022Renal Cell Carcinoma
FDA approves futibatinib (Lytgobi) for certain biliary tract cancersOctober 3, 2022Gastrointestinal Cancer
Image-guided superficial radiation as first-line in skin cancer?October 3, 2022Nonmelanoma Skin Cancer
Risk-adapted screening strategy could reduce colonoscopy useOctober 3, 2022GastroenterologyGastrointestinal Cancer
Could your patients benefit? New trials in noncolorectal GI cancerSeptember 30, 2022Gastrointestinal Cancer
Cost paramount when choosing metastatic breast cancer treatmentSeptember 30, 2022Metastatic Breast CancerBreast Cancer
Out-of-state telehealth visits could help more patients if restrictions eased: StudySeptember 28, 2022Practice Management
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerHead & Neck/Thyroid CancersMelanomaGastrointestinal CancerGenitourinary Cancer
Britain’s hard lessons from handing elder care over to private equitySeptember 28, 2022Practice Management
Neoadjuvant immunotherapy shows promise for resectable CSCCSeptember 27, 2022Head & Neck/Thyroid Cancers
